ROYAL BANK OF CANADA - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 81 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$16,000
+6.7%
1,341
+6.9%
0.00%
Q2 2023$15,0001,255
+15587.5%
0.00%
Q1 2023$080.0%0.00%
Q4 2022$0
-100.0%
8
-99.8%
0.00%
Q3 2022$13,000
-38.1%
3,539
+0.9%
0.00%
Q2 2022$21,000
-4.5%
3,5080.0%0.00%
Q1 2022$22,000
+57.1%
3,508
-0.3%
0.00%
Q4 2021$14,000
+40.0%
3,517
+75.1%
0.00%
Q3 2021$10,000
-23.1%
2,0080.0%0.00%
Q2 2021$13,0000.0%2,0080.0%0.00%
Q1 2021$13,0002,008
+3485.7%
0.00%
Q4 2020$0
-100.0%
56
-79.8%
0.00%
Q3 2020$1,0000.0%277
-13.2%
0.00%
Q2 2020$1,000319
-17.4%
0.00%
Q1 2020$0386
+72.3%
0.00%
Q4 2019$0
-100.0%
224
+32.5%
0.00%
Q3 2019$1,0000.0%169
+9.0%
0.00%
Q2 2019$1,0000.0%1550.0%0.00%
Q1 2019$1,0000.0%1550.0%0.00%
Q4 2018$1,000
-99.7%
155
-99.8%
0.00%
Q3 2018$378,000
+5.9%
70,812
-2.6%
0.00%
Q2 2018$357,000
-38.8%
72,735
+0.3%
0.00%
Q1 2018$583,000
-19.6%
72,492
+2.5%
0.00%
Q4 2017$725,000
-30.7%
70,755
-1.7%
0.00%
-100.0%
Q3 2017$1,046,00071,9760.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Newtyn Management, LLC 362,335$3,714,0000.57%
Rubric Capital Management LP 410,244$4,205,0000.52%
WITTENBERG INVESTMENT MANAGEMENT, INC. 83,811$859,0000.37%
Yakira Capital Management, Inc. 83,969$861,0000.28%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$153,0000.10%
STONEBRIDGE CAPITAL MANAGEMENT INC 18,550$200,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 66,498$681,0000.05%
Cannell & Co. 75,467$774,0000.03%
Trexquant Investment LP 21,347$219,0000.02%
PDT Partners, LLC 58,004$595,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders